These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1696447)

  • 1. Quantitative analysis of epidermal growth factor in human benign prostatic hyperplasia and prostatic carcinoma and its prognostic significance.
    Shaikh N; Lai L; McLoughlin J; Clark D; Williams G
    Anticancer Res; 1990; 10(4):873-4. PubMed ID: 1696447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):333-42. PubMed ID: 9156044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.
    Ho PJ; Baxter RC
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
    Soulitzis N; Karyotis I; Delakas D; Spandidos DA
    Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
    Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth factors and benign prostatic hyperplasia].
    Boroian R
    Georgian Med News; 2007 Nov; (152):18-22. PubMed ID: 18175827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid hormone receptors and endocrine response of prostatic carcinoma.
    Jasper WS; Abou-Issa H; Gogate SA; Snider GB
    Cancer Detect Prev; 1987; 10(5-6):393-9. PubMed ID: 2436783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
    Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Organ culture of human tissue as study model of hormonal and pharmacological regulation of benign prostatic hyperplasia and of prostatic cancer].
    Janssen T; Kiss R; Schulman C
    Acta Urol Belg; 1995 Mar; 63(1):7-14. PubMed ID: 7537011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone--related protein (PTHrP) is an epidermal growth factor-regulated secretory product of human prostatic epithelial cells.
    Cramer SD; Peehl DM; Edgar MG; Wong ST; Deftos LJ; Feldman D
    Prostate; 1996 Jul; 29(1):20-9. PubMed ID: 8685051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide hormones, serotonin, and other cell differentiation markers in benign hyperplasia and in carcinoma of the prostate.
    Abrahamsson PA; Alumets J; Wadström LB; Falkmer S; Grimelius L
    Prog Clin Biol Res; 1987; 243A():489-502. PubMed ID: 2443920
    [No Abstract]   [Full Text] [Related]  

  • 13. Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma.
    Enokida H; Shiina H; Urakami S; Terashima M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Igawa M; Dahiya R
    Cancer; 2006 Jan; 106(1):79-86. PubMed ID: 16323173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Activity of protein C in blood of patients with prostatic carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Tyloch F; Zastawna E
    Pol Tyg Lek; 1996 Feb; 51(6-9):94-5. PubMed ID: 8756742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [P53 expression and its clinical significance in prostatic carcinoma].
    Jiang T; Jiang H; Song XS; Li XC; Li QL
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):448-51, 454. PubMed ID: 15999492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB; Kudlow JE; Grizzle WE
    Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical studies on endocrine therapy of prostatic carcinoma (1): Multivariate analyses of prognostic factors in patients with prostatic carcinoma given endocrine therapy].
    Kumamoto Y; Tsukamoto T; Umehara T; Shimazaki J; Fuse H; Ohshima H; Takeuchi H; Yoshida O; Okada K; Saito Y
    Hinyokika Kiyo; 1990 Mar; 36(3):275-84. PubMed ID: 2191569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N; Wion D; Brachet P; Djakiew D
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.